These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9745506)
1. GvHD after small bowel transplantation: the role of caspases, FAS-L, and galectin-1. Fändrich F; Zepernick-Kalinski C; Lin X Transplant Proc; 1998 Sep; 30(6):2594-5. PubMed ID: 9745506 [No Abstract] [Full Text] [Related]
2. Cytokine profile in graft-versus-host disease after small bowel transplantation. Galvao FH; Murase N; Todo S; Zeevi A; Ye Q; Doughton CS; Demetris AJ; Waitzberg DL; Fung JJ; Starzl TE Transplant Proc; 1996 Oct; 28(5):2455. PubMed ID: 8907897 [No Abstract] [Full Text] [Related]
3. Early detection of the Fas-FasL system in hepatic graft-versus-host disease after rat small-bowel transplantation. Shiraishi M; Hiroyasu S; Koji T; Muto Y; Koyama Y Transplant Proc; 1999; 31(1-2):567-8. PubMed ID: 10083239 [No Abstract] [Full Text] [Related]
4. The role of Fas/FasL apoptotic pathway in the development of chronic rejection. Subbotin V; Sun H; Aitouche A; Salam A; Valdivia LA; Fung JJ; Starzl TE; Rao AS Transplant Proc; 1999; 31(1-2):1397-8. PubMed ID: 10083618 [No Abstract] [Full Text] [Related]
5. Role of donor natural killer cells on lethal graft-versus-host disease following small bowel transplantation in the rat. Okamoto M; Arakawa K; Akioka K; Fujiwara I; Takeshita K; Oka T Transplant Proc; 1996 Oct; 28(5):2467-8. PubMed ID: 8907905 [No Abstract] [Full Text] [Related]
6. Impact of natural killer cells in mediating graft-versus-host disease following small bowel transplantation in a rat model. Fändrich F; Exner B; Papachrysanthou A; Jahnke T; Chambers WH; Zavazava N Transplant Proc; 1996 Oct; 28(5):2465-6. PubMed ID: 8907904 [No Abstract] [Full Text] [Related]
7. Tissue-specific immune response: the role of innate immunity in small bowel and heart transplantation. Dresske B; Zavazava N; Brötzmann K; Kremer B; Fändrich F Transplant Proc; 1998 Sep; 30(6):2566-7. PubMed ID: 9745490 [No Abstract] [Full Text] [Related]
8. CD95L confers immune priviledge to liver grafts which are spontaneously accepted. Fändrich F; Lin X; Zhu X; Klöppel G; Parwaresch R; Kremer B Transplant Proc; 1998 Jun; 30(4):1057-8. PubMed ID: 9636427 [No Abstract] [Full Text] [Related]
9. Use of CD14 and lipopolysaccharide binding protein mRNA expression as markers for acute rejection in rat small bowel transplantation. Cicalese L; Freeswick PD; Watkins SC; Kelly E; Zeidan M; Rao AS; Stanko RT Transplant Proc; 1996 Oct; 28(5):2470. PubMed ID: 8907907 [No Abstract] [Full Text] [Related]
10. Adenovirus-mediated gene transfer of Bcl-2 in graft-versus-host disease after rat intestinal transplantation. Shiraishi M; Taira K; Sugawa H; Osiro T; Muto Y Transplant Proc; 2000 Sep; 32(6):1263-4. PubMed ID: 10995939 [No Abstract] [Full Text] [Related]
11. Natural killer activity is down-regulated following allogeneic small bowel transplantation. Tice DG Transplant Proc; 1992 Jun; 24(3):1135-6. PubMed ID: 1604554 [No Abstract] [Full Text] [Related]
12. In vivo changes in acute rejection of rat small bowel allografts. Stojanovic T; Schlemminger R; Bedke J; Gröne HJ; Heuser M; Leister I; Hecker M; Becker H; Markus PM Transplant Proc; 2000 Sep; 32(6):1247-8. PubMed ID: 10995931 [No Abstract] [Full Text] [Related]
13. The role of natural killer cell mediated caspases activation in a graft-versus-host disease model of semiallogeneic small bowel transplantation. Fändrich F; Zepernick-Kalinski C; Gebhardt H; Henne-Bruns D; Zavazava N; Lin X Transpl Immunol; 1999 Mar; 7(1):1-7. PubMed ID: 10375071 [TBL] [Abstract][Full Text] [Related]
14. Investigations of the immunoprotective role of the liver after allogeneic orthotopic combined liver-small-bowel transplantation in the rat. Gassel HJ; Timmermann W; Meyer D; Gassel AM; Thiede A Transplant Proc; 1997; 29(1-2):693-4. PubMed ID: 9123484 [No Abstract] [Full Text] [Related]
15. Modulation of graft-vs-host-related disease by host-specific natural killer cell activity following semiallogeneic small bowel transplantation in the rat. Fändrich F; Schröder J; Jahnke T; Dresske B; Chambers WH; Zavazava N Transplant Proc; 1996 Dec; 28(6):3267-8. PubMed ID: 8962268 [No Abstract] [Full Text] [Related]
16. Met-RANTES improves acute-rejection-induced microvascular injury in rat small bowel transplantation. Bedke J; Stojanovic T; Gröne HJ; Heuser M; Scheele L; Proudfoot AE; Becker H; Markus PM; Hecker M Transplant Proc; 2002 May; 34(3):1049. PubMed ID: 12034300 [No Abstract] [Full Text] [Related]
17. Orthotopic liver transplantation can protect small bowel free grafts from rejection. Lee SK; Perez-Atayde A; Vacanti JP; Lund DP Transplant Proc; 1994 Aug; 26(4):2300-1. PubMed ID: 8066757 [No Abstract] [Full Text] [Related]
18. Hematologic parameters are improved by inhibition of NO synthesis during graft-versus-host disease after small bowel transplantation. Langrehr JM; Machens C; Koch S; Zill E; Leder K; Neuhaus P Transplant Proc; 2000 Sep; 32(6):1288-9. PubMed ID: 10995951 [No Abstract] [Full Text] [Related]
19. Mechanism of graft-versus-host disease and inhibition with deoxyspergualin on small bowel transplantation in rats. Tanaka S; Okada H; Uda K; Fujioka M; Makabe M; Orita T; Orita K Transplant Proc; 1992 Jun; 24(3):1161-3. PubMed ID: 1604569 [No Abstract] [Full Text] [Related]
20. Serum and bile individual bile acid changes as a noninvasive marker of small bowel allograft rejection in rats. Miyagi K; Kiyochi H; Honda K; Kobayashi K Transplant Proc; 2000 Sep; 32(6):1265-6. PubMed ID: 10995940 [No Abstract] [Full Text] [Related] [Next] [New Search]